Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950
SE Corcoran, R Halai, MA Cooper - Pharmacological reviews, 2021 - ASPET
Activation of the Nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome
drives release of the proinflammatory cytokines interleukin (IL)-1 β and IL-18 and induces …
drives release of the proinflammatory cytokines interleukin (IL)-1 β and IL-18 and induces …
IL-1 signaling in tumor microenvironment
W Zhang, N Borcherding, R Kolb - … : The Role of Interleukins–Part A, 2020 - Springer
Abstract Interleukin 1 (IL-1) has long been known for its pleiotropic effects on inflammation
that plays a complex, and sometimes contrasting, role in different stages of cancer …
that plays a complex, and sometimes contrasting, role in different stages of cancer …
[HTML][HTML] β-Glucan-induced trained immunity protects against Leishmania braziliensis infection: a crucial role for IL-32
JC Dos Santos, AMB de Figueiredo, MVT Silva… - Cell reports, 2019 - cell.com
American tegumentary leishmaniasis is a vector-borne parasitic disease caused by
Leishmania protozoans. Innate immune cells undergo long-term functional reprogramming …
Leishmania protozoans. Innate immune cells undergo long-term functional reprogramming …
[HTML][HTML] NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
LA Sacramento, C Farias Amorim… - PLOS Neglected …, 2023 - journals.plos.org
Cutaneous leishmaniasis exhibits a spectrum of clinical presentations dependent upon the
parasites' persistence and host immunopathologic responses. Although cytolytic CD8 T cells …
parasites' persistence and host immunopathologic responses. Although cytolytic CD8 T cells …
Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis
Patients infected with Leishmania braziliensis develop chronic lesions that often fail to
respond to treatment with antiparasite drugs. To determine whether genes whose …
respond to treatment with antiparasite drugs. To determine whether genes whose …
Senescent T cells: Beneficial and detrimental roles
P Laphanuwat, DCO Gomes… - Immunological Reviews, 2023 - Wiley Online Library
As the thymus involutes during aging, the T‐cell pool has to be maintained by the periodic
expansion of preexisting T cells during adulthood. A conundrum is that repeated episodes of …
expansion of preexisting T cells during adulthood. A conundrum is that repeated episodes of …
Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs
Leishmaniasis is a disease complex caused by 20 species of protozoan parasites belonging
to the genus Leishmania. In humans, it has two main clinical forms, visceral leishmaniasis …
to the genus Leishmania. In humans, it has two main clinical forms, visceral leishmaniasis …
Drug discovery for kinetoplastid diseases: future directions
SPS Rao, MP Barrett, G Dranoff, CJ Faraday… - ACS infectious …, 2018 - ACS Publications
Kinetoplastid parasites have caused human disease for millennia. Significant achievements
have been made toward developing new treatments for leishmaniasis (particularly on the …
have been made toward developing new treatments for leishmaniasis (particularly on the …
Regulatory T cells control Staphylococcus aureus and disease severity of cutaneous leishmaniasis
TP Singh, C Farias Amorim, VM Lovins… - Journal of Experimental …, 2023 - rupress.org
Cutaneous leishmaniasis causes alterations in the skin microbiota, leading to pathologic
immune responses and delayed healing. However, it is not known how these microbiota …
immune responses and delayed healing. However, it is not known how these microbiota …
Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo
Background Keratinocytes can function as innate immune cells under oxidative stress and
aggravate the cutaneous T-cell response that undermines melanocytes in the setting of …
aggravate the cutaneous T-cell response that undermines melanocytes in the setting of …